8-K
filed November 6, 2025, 6:59 PM ET
ticker BNKK
CIK 0001760903
leadership
confidence high
sentiment positive
materiality 0.75
Bonk appoints three directors, gains Bonk-aligned board majority; Nasdaq compliance matter closed
BONK, INC.
- Board adds Connor Klein (New Form Capital), Stacey Duffy (financial due diligence), Jamie McAvity (Cormint CEO); Schur and Pascucci resign.
- New majority of 4 recent appointments (including Mitchell Rudy) gives Bonk-aligned members 4 of 7 board seats.
- Nasdaq staff determined prior private placements violated Listing Rules 5635 and 5640; corrective actions restored compliance and matter closed.
- Board refresh aims to support new strategy centered on BONK Holdings LLC in DeFi and digital assets.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-25-021094
- form_type
- 8-K
- ticker
- BNKK
- cik
- 0001760903
- company_name
- BONK, INC.
- filed_at
- 2025-11-06T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:40.358369+00:00
- generated_at
- 2026-05-16T23:52:16.719907+00:00
- sec_items
- ["3.01", "5.02", "9.01"]
- event_type
- leadership
- sentiment
- positive
- materiality_score
- 0.75
- calibrated_materiality_score
- 0.75
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-25-021094
- json_url
- https://secwatch.observer/filing/0001493152-25-021094.json
- markdown_url
- https://secwatch.observer/filing/0001493152-25-021094.md
- text_url
- https://secwatch.observer/filing/0001493152-25-021094.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1760903/000149315225021094/0001493152-25-021094-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1760903/000149315225021094/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
INV
Innventure appoints John Hewitt to board, nominates Catriona Fallon after director resignation
Innventure, Inc.
April 30, 2026, 7:59 PM ET
leadership
Items 3.01, 5.02, 8.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 5.02, 9.01
same event type: leadership
similar materiality
This filing
) that the previously disclosed private placements that the Company entered into on
August 8, 2025 and August 29, 2025 (the “Transactions”) together and individually failed to comply with the following Nasdaq
Listing Rules (the “Rules”): (i) notification requirements under Listing Rules 5250(b)(1), 5250(e)(2)(B) and 5250(e)(2)(D);
(ii) Shareholder Approval requirements under Listing Rules 5635(a) and 5635(b); and (iii) Voting Rights requirements under Listing Rule
5640. The
Letter further stated that based on the Company’s corrective actions to amend the Transactions and subsequent disclosures
Comparable filing
April 29, 2026. On April 29, 2026, the Company informed The Nasdaq Stock Market LLC (“Nasdaq”) that, as a result of Mr. Hennessy’s resignation from the Board and the Audit Committee, the Company was rendered noncompliant
Filing page
SEC filing
RANI
Rani Therapeutics Q1 net loss narrows to $8M; Nasdaq bid price non-compliance; CFO to depart
Rani Therapeutics Holdings, Inc.
May 15, 2026, 4:08 PM ET
earnings
Items 2.02, 3.01, 5.02, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 5.02, 9.01
similar materiality
This filing
) that the previously disclosed private placements that the Company entered into on
August 8, 2025 and August 29, 2025 (the “Transactions”) together and individually failed to comply with the following Nasdaq
Listing Rules (the “Rules”): (i) notification requirements under Listing Rules 5250(b)(1), 5250(e)(2)(B) and 5250(e)(2)(D);
(ii) Shareholder Approval requirements under Listing Rules 5635(a) and 5635(b); and (iii) Voting Rights requirements under Listing Rule
5640. The
Letter further stated that based on the Company’s corrective actions to amend the Transactions and subsequent disclosures
Comparable filing
May 11, 2026, the Company received a letter from the Nasdaq Stock Exchange LLC (“Nasdaq”), notifying the Company that, based on the closing bid price of the Company’s Class A common stock, par value $0.0001 per share (th
Filing page
SEC filing
GENC
Gencor receives NYSE American delinquency notice for late Q2 2026 10-Q filing
GENCOR INDUSTRIES INC
June 1, 2026, 4:09 PM ET
regulatory
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
similar materiality
This filing
) that the previously disclosed private placements that the Company entered into on
August 8, 2025 and August 29, 2025 (the “Transactions”) together and individually failed to comply with the following Nasdaq
Listing Rules (the “Rules”): (i) notification requirements under Listing Rules 5250(b)(1), 5250(e)(2)(B) and 5250(e)(2)(D);
(ii) Shareholder Approval requirements under Listing Rules 5635(a) and 5635(b); and (iii) Voting Rights requirements under Listing Rule
5640. The
Letter further stated that based on the Company’s corrective actions to amend the Transactions and subsequent disclosures
Comparable filing
May 19, 2026, Gencor Industries, Inc. (the “Company”) received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company was not in compliance with the NYSE American LLC (“NYSE American”) continued listing standards as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”) with the Securities and Exchange Commission (“SEC”) prior to May 18, 2026, the end of the extension period provided by Form 12b-25, and as a result was subject to the procedures set forth in Section 1007 of the NY
Filing page
SEC filing
ATNM
Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26
Actinium Pharmaceuticals, Inc.
May 29, 2026, 5:10 PM ET
regulatory
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
similar materiality
This filing
) that the previously disclosed private placements that the Company entered into on
August 8, 2025 and August 29, 2025 (the “Transactions”) together and individually failed to comply with the following Nasdaq
Listing Rules (the “Rules”): (i) notification requirements under Listing Rules 5250(b)(1), 5250(e)(2)(B) and 5250(e)(2)(D);
(ii) Shareholder Approval requirements under Listing Rules 5635(a) and 5635(b); and (iii) Voting Rights requirements under Listing Rule
5640. The
Letter further stated that based on the Company’s corrective actions to amend the Transactions and subsequent disclosures
Comparable filing
May 27, 2026, Actinium Pharmaceuticals, Inc.
(the “Company”) received a notice (the “Notice”) from NYSE American LLC (“NYSE American”) indicating
that the Company is not in compliance with the continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company
Guide (the “Company Guide”), which requires a listed company to maintain stockholders’ equity of $4.0 million or more
if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. As of March 31,
2026, the Company reported stockholders’ equity of approximately
Filing page
SEC filing
CSAI
Cloudastructure receives Nasdaq delinquency notice for late Q1 10-Q filing
CLOUDASTRUCTURE, INC.
May 29, 2026, 5:09 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
similar materiality
This filing
) that the previously disclosed private placements that the Company entered into on
August 8, 2025 and August 29, 2025 (the “Transactions”) together and individually failed to comply with the following Nasdaq
Listing Rules (the “Rules”): (i) notification requirements under Listing Rules 5250(b)(1), 5250(e)(2)(B) and 5250(e)(2)(D);
(ii) Shareholder Approval requirements under Listing Rules 5635(a) and 5635(b); and (iii) Voting Rights requirements under Listing Rule
5640. The
Letter further stated that based on the Company’s corrective actions to amend the Transactions and subsequent disclosures
Comparable filing
May 26, 2026, Cloudastructure,
Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Listing Qualifications staff of The Nasdaq
Stock Market LLC (“Nasdaq”) indicating that, as a result of not having timely filed its Quarterly Report on Form 10-Q for
the period ended March 31, 2026 (“Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which
requires timely filing of all required periodic financial reports with the Securities and Exchange Commission. The Company requires additional
time to review and confirm the accounting treatment for its outstand
Filing page
SEC filing
GURE
Gulf Resources receives Nasdaq delisting notice for late Q1 2026 10-Q filing
GULF RESOURCES, INC.
May 29, 2026, 4:45 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
similar materiality
This filing
) that the previously disclosed private placements that the Company entered into on
August 8, 2025 and August 29, 2025 (the “Transactions”) together and individually failed to comply with the following Nasdaq
Listing Rules (the “Rules”): (i) notification requirements under Listing Rules 5250(b)(1), 5250(e)(2)(B) and 5250(e)(2)(D);
(ii) Shareholder Approval requirements under Listing Rules 5635(a) and 5635(b); and (iii) Voting Rights requirements under Listing Rule
5640. The
Letter further stated that based on the Company’s corrective actions to amend the Transactions and subsequent disclosures
Comparable filing
May 26, 2026, Gulf Resources
(the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq
Stock Market LLC (“Nasdaq”), indicating that, as a result of not having timely filed its quarterly report on Form 10-Q for
the quarter ended March 31, 2026 (the “Form 10-Q”), and the Company remains delinquent in filing its annual report on Form
10-K for the year ended December 31, 2025 (the “Initial Delinquent Filing”), the Company is in non-compliance with Nasdaq
Listing Rule 5250(c)(1), which requires timely filing all required periodic financial reports wit
Filing page
SEC filing
ONFO
Onfolio receives Nasdaq delisting notice for insufficient equity ($1.22M vs $2.5M min)
Onfolio Holdings, Inc
May 29, 2026, 4:30 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
similar materiality
This filing
) that the previously disclosed private placements that the Company entered into on
August 8, 2025 and August 29, 2025 (the “Transactions”) together and individually failed to comply with the following Nasdaq
Listing Rules (the “Rules”): (i) notification requirements under Listing Rules 5250(b)(1), 5250(e)(2)(B) and 5250(e)(2)(D);
(ii) Shareholder Approval requirements under Listing Rules 5635(a) and 5635(b); and (iii) Voting Rights requirements under Listing Rule
5640. The
Letter further stated that based on the Company’s corrective actions to amend the Transactions and subsequent disclosures
Comparable filing
May 26, 2026, Onfolio Holdings Inc. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) informing the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market. The Notice states that the Company’s Quarterly Report on Form 10-Q for the for the period ended March 31, 2026 reported stockholders’ equity of $1,216,603. As of the date of the Notice
Filing page
SEC filing
ADTX
Aditxt receives Nasdaq deficiency for negative equity; delisting hearing set for June 11
Aditxt, Inc.
May 29, 2026, 4:21 PM ET
other_material
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 9.01
similar materiality
This filing
) that the previously disclosed private placements that the Company entered into on
August 8, 2025 and August 29, 2025 (the “Transactions”) together and individually failed to comply with the following Nasdaq
Listing Rules (the “Rules”): (i) notification requirements under Listing Rules 5250(b)(1), 5250(e)(2)(B) and 5250(e)(2)(D);
(ii) Shareholder Approval requirements under Listing Rules 5635(a) and 5635(b); and (iii) Voting Rights requirements under Listing Rule
5640. The
Letter further stated that based on the Company’s corrective actions to amend the Transactions and subsequent disclosures
Comparable filing
May 27, 2026, Aditxt, Inc. (the “Company”)
received a letter (the “Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market
LLC (“Nasdaq”) notifying the Company that, based on the stockholders’ equity of $(35,174,386) reported in the Company’s
Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company no longer satisfies the minimum
stockholders’ equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1)
(the “Stockholders’ Equity Requirement”). The Letter further
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.